Global Developments: AI Progress, Pharma Queries, and Tech Alliances
Recent headlines from the Financial Times highlight China's testing of new AI chip-making tools, questions in the UK about potential coordination in reduced pharma sector spending, expansion of leadership at BlackRock, and significant investments by US tech giants in UK infrastructure.
In a bid to challenge Western counterparts in AI processor production, China's Semiconductor Manufacturing International Corporation is reportedly testing an advanced DUV lithography machine developed by a Shanghai-based start-up.
Meanwhile, in the UK, queries have arisen within the government about whether pharmaceutical companies, such as Eli Lilly, Merck, and AstraZeneca, are coordinating efforts to influence state drug spending, following their announcements to reduce investments.
Additionally, in a reorganization move, BlackRock has expanded its leadership team, while major US tech companies plan to invest billions in UK computing infrastructure, marking a significant tech alliance embraced by British and US leaders.
(With inputs from agencies.)
Google News